Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4

Respiratory Research

Volumn 12, Issue , 2011, Pages

  Botturi, Karine ^a,b,c   Lacoeuille, Yannick ^a,b   Cavaillès, Arnaud ^a,b,c   Vervloet, Daniel ^d   Magnan, Antoine ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c L INSTITUT DU THORAX   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INDUCIBLE T CELL COSTIMULATOR LIGAND; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; TRANSCRIPTION FACTOR FOXP3; CYTOKINE; CYTOTOXIC T-LYMPHOCYTE ANTIGEN 4; HOUSE DUST ALLERGEN; INDUCIBLE T CELL CO STIMULATOR; INDUCIBLE T-CELL CO-STIMULATOR; LEUKOCYTE ANTIGEN; T LYMPHOCYTE ANTIGEN;

ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DERMATOPHAGOIDES; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE ACTIVATION; ASTHMA; CELL CULTURE; COMPARATIVE STUDY; HYPERSENSITIVITY; IMMUNOLOGY; INTRACUTANEOUS TEST; LYMPHOCYTE ACTIVATION; METABOLISM; MIDDLE AGED; PERENNIAL RHINITIS; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ADULT; ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, DERMATOPHAGOIDES; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; ASTHMA; CELLS, CULTURED; CYTOKINES; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERSENSITIVITY; INTRADERMAL TESTS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; RHINITIS, ALLERGIC, PERENNIAL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 79952066775     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-12-25     Document Type: Article

References (33)

1. Janson C, Anto J, Burney P, Chinn S, de Marco R, Heinrich J, Jarvis D, Kuenzli N, Leynaert B, Luczynska C, et al. The European Community Respiratory Health Survey: what are the main results so far? European Community Respiratory Health Survey II. Eur Respir J 2001, 18:598-611. 10.1183/09031936.01.00205801, 11589359.
2. Huang SK, Xiao HQ, Kleine-Tebbe J, Paciotti G, Marsh DG, Lichtenstein LM, Liu MC. IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 1995, 155:2688-2694.
3. Humbert M, Durham SR, Kimmitt P, Powell N, Assoufi B, Pfister R, Menz G, Kay AB, Corrigan CJ. Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma. J Allergy Clin Immunol 1997, 99:657-665. 10.1016/S0091-6749(97)70028-9, 9155833.
4. Jutel M, Akdis M, Budak F, Aebischer-Casaulta C, Wrzyszcz M, Blaser K, Akdis CA. IL-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 2003, 33:1205-1214. 10.1002/eji.200322919, 12731045.
5. Stock P, DeKruyff RH, Umetsu DT. Inhibition of the allergic response by regulatory T cells. Curr Opin Allergy Clin Immunol 2006, 6:12-16. 10.1097/01.all.0000200502.69672.44, 16505606.
6. Van Overtvelt L, Wambre E, Maillere B, von Hofe E, Louise A, Balazuc AM, Bohle B, Ebo D, Leboulaire C, Garcia G, Moingeon P. Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J Immunol 2008, 180:4514-4522.
7. Ling EM, Smith T, Nguyen XD, Pridgeon C, Dallman M, Arbery J, Carr VA, Robinson DS. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004, 363:608-615. 10.1016/S0140-6736(04)15592-X, 14987885.
8. Akdis M, Verhagen J, Taylor A, Karamloo F, Karagiannidis C, Crameri R, Thunberg S, Deniz G, Valenta R, Fiebig H, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004, 199:1567-1575. 10.1084/jem.20032058, 2211782, 15173208.
9. Mamessier E, Nieves A, Lorec AM, Dupuy P, Pinot D, Pinet C, Vervloet D, Magnan A. T-cell activation during exacerbations: a longitudinal study in refractory asthma. Allergy 2008, 63:1202-1210. 10.1111/j.1398-9995.2008.01687.x, 18699937.
10. Magnan AO, Mely LG, Camilla CA, Badier MM, Montero-Julian FA, Guillot CM, Casano BB, Prato SJ, Fert V, Bongrand P, Vervloet D. Assessment of the Th1/Th2 paradigm in whole blood in atopy and asthma. Increased IFN-gamma-producing CD8(+) T cells in asthma. Am J Respir Crit Care Med 2000, 161:1790-1796.
11. Krug N, Madden J, Redington AE, Lackie P, Djukanovic R, Schauer U, Holgate ST, Frew AJ, Howarth PH. T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma. Am J Respir Cell Mol Biol 1996, 14:319-326.
12. Cho SH, Stanciu LA, Holgate ST, Johnston SL. Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am J Respir Crit Care Med 2005, 171:224-230. 10.1164/rccm.200310-1416OC, 15502111.
13. Beier KC, Kallinich T, Hamelmann E. Master switches of T-cell activation and differentiation. Eur Respir J 2007, 29:804-812. 10.1183/09031936.00094506, 17400879.
14. Kopf M, Coyle AJ, Schmitz N, Barner M, Oxenius A, Gallimore A, Gutierrez-Ramos JC, Bachmann MF. Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J Exp Med 2000, 192:53-61. 10.1084/jem.192.1.53, 1887704, 10880526.
15. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005, 23:515-548. 10.1146/annurev.immunol.23.021704.115611, 15771580.
16. Kolar P, Knieke K, Hegel JK, Quandt D, Burmester GR, Hoff H, Brunner-Weinzierl MC. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice. Arthritis Rheum 2009, 60:123-132. 10.1002/art.24181, 19116935.
17. Schmitz V, Neumann UP, Fischer U, Langrehr J, Neuhaus P. Induction of long-term graft acceptance by a combination treatment of donor splenocytes and CTLA4Ig in a high responder rat liver transplantation model. Transpl Int 2005, 18:1187-1196. 10.1111/j.1432-2277.2005.00193.x, 16162106.
18. Wiley RE, Goncharova S, Shea T, Johnson JR, Coyle AJ, Jordana M. Evaluation of inducible costimulator/B7-related protein-1 as a therapeutic target in a murine model of allergic airway inflammation. Am J Respir Cell Mol Biol 2003, 28:722-730. 10.1165/rcmb.2002-0220OC, 12760969.
19. National Institut of Health Global Strategy for asthma management and prevention. 2006, NIH Publication, National Institut of Health., http://www.Ginasthma.org
20. Richter A, Lohning M, Radbruch A. Instruction for cytokine expression in T helper lymphocytes in relation to proliferation and cell cycle progression. J Exp Med 1999, 190:1439-1450. 10.1084/jem.190.10.1439, 2195692, 10562319.
21. Boniface S, Koscher V, Mamessier E, El Biaze M, Dupuy P, Lorec AM, Guillot C, Badier M, Bongrand P, Vervloet D, Magnan A. Assessment of T lymphocyte cytokine production in induced sputum from asthmatics: a flow cytometry study. Clin Exp Allergy 2003, 33:1238-1243. 10.1046/j.1365-2222.2003.01762.x, 12956745.
22. Botturi K, Lacoeuille Y, Thomas P, Boniface S, Reynaud-Gaubert M, Magnan A. CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients. Eur Respir J 2008, 31:1167-1176. 10.1183/09031936.00093207, 18256061.
23. Magnan A, Humbert M. Is deficient tolerance the true paradigm for atopic diseases?. Clin Exp Allergy 2005, 35:1507-1510. 10.1111/j.1365-2222.2005.02392.x, 16393315.
24. Lordan JL, Davies DE, Wilson SJ, Dent G, Corkhill A, Jaffar Z, Roberts K, Djukanovic R, Holgate ST. The role of CD28-B7 costimulation in allergen-induced cytokine release by bronchial mucosa from patients with moderately severe asthma. J Allergy Clin Immunol 2001, 108:976-981. 10.1067/mai.2001.119740, 11742276.
25. Tsushima F, Yao S, Shin T, Flies A, Flies S, Xu H, Tamada K, Pardoll DM, Chen L. Interaction between B7-H1 and PD-1 determines initiation and reversal of T-cell anergy. Blood 2007, 110:180-185. 10.1182/blood-2006-11-060087, 1896111, 17289811.
26. Meiler F, Zumkehr J, Klunker S, Ruckert B, Akdis CA, Akdis M. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 2008, 205:2887-2898. 10.1084/jem.20080193, 2585856, 19001136.
27. Coyle AJ, Lehar S, Lloyd C, Tian J, Delaney T, Manning S, Nguyen T, Burwell T, Schneider H, Gonzalo JA, et al. The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity 2000, 13:95-105. 10.1016/S1074-7613(00)00011-X, 10933398.
28. Gonzalo JA, Tian J, Delaney T, Corcoran J, Rottman JB, Lora J, Al-garawi A, Kroczek R, Gutierrez-Ramos JC, Coyle AJ. ICOS is critical for T helper cell-mediated lung mucosal inflammatory responses. Nat Immunol 2001, 2:597-604. 10.1038/89739, 11429543.
29. Coyle AJ, Gutierrez-Ramos JC. The role of ICOS and other costimulatory molecules in allergy and asthma. Springer Semin Immunopathol 2004, 25:349-359. 10.1007/s00281-003-0154-y, 14999428.
30. Lohning M, Hutloff A, Kallinich T, Mages HW, Bonhagen K, Radbruch A, Hamelmann E, Kroczek RA. Expression of ICOS in vivo defines CD4+ effector T cells with high inflammatory potential and a strong bias for secretion of interleukin 10. J Exp Med 2003, 197:181-193. 10.1084/jem.20020632, 2193816, 12538658.
31. Chen YQ, Shi HZ. CD28/CTLA-4--CD80/CD86 and ICOS--B7RP-1 costimulatory pathway in bronchial asthma. Allergy 2006, 61:15-26. 10.1111/j.1398-9995.2006.01008.x, 16364152.
32. Suntharalingam G, Perry MR, Ward S, Brett SJ, Castello-Cortes A, Brunner MD, Panoskaltsis N. Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412. N Engl J Med 2006, 355:1018-1028. 10.1056/NEJMoa063842, 16908486.
33. Provoost S, Maes T, van Durme YM, Gevaert P, Bachert C, Schmidt-Weber CB, Brusselle GG, Joos GF, Tournoy KG. Decreased FOXP3 protein expression in patients with asthma. Allergy 2009, 64:1539-1546. 10.1111/j.1398-9995.2009.02056.x, 19392991.